The Food and Drug Administration Friday issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. Among other recommendations, FDA recommends providers carefully follow the stapler manufacturer’s instructions for use, have a range of staple sizes available and select the appropriate size cartridge for the tissue. Since 2011, the agency has received more than 41,000 medical device reports for surgical staplers and staples for internal use, including 366 deaths. FDA plans this year to issue draft guidance to manufacturers on information to include in their product labeling and to hold a public meeting on whether to reclassify the staplers as Class II devices, which would allow the agency to establish mandatory special controls to mitigate known risks.

Related News Articles

Headline
The Department of Health and Human Services’ Office of the Inspector General says it will seek to ensure health care providers retain regulatory flexibility…
Headline
The Department of Health and Human Services' Office for Civil Rights April 3 warned HIPAA-covered entities of an individual posing as an OCR investigator…
Headline
The federal government will use a portion of the Coronavirus Aid, Relief, and Economic Security Act’s $100 billion emergency fund for hospitals and health care…
Headline
The AHA today urged CMS to use its authority to extend to LTCHs the 20% hospital add-on payment for Medicare beneficiaries diagnosed with COVID-19, which was…
Headline
The AHA urged HHS and CMS to consider taking additional actions that would expand the ability of hospitals and health systems to use telehealth in response to…
Headline
The AHA urged the HHS Secretary to consider additional actions to temporarily suspend certain requirements so that health care providers can better respond to…